EKR Therapeutics, Inc. Announces Management Additions and Promotions, Reflecting Support of Continued Acceleration in Growth

CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on acquiring, commercializing and maximizing the potential of proprietary acute-care products, today announced additions to its senior management staff including Ernie Biczak, M.D. as Senior Vice President of Marketing, Dave Iwanicki as Senior Vice President of Commercial Operations, and Stephen Hulse, R.Ph. as Vice President of Sales. Additionally, Tong Zhang, Ph.D. has been promoted to Vice President of Business Development.